Showing results (301-310 of 3,017) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|October 4, 2019
Relationship between SNP rs1764391 and Susceptibility, Risk Factors, Gene-environment Interactions of Acute Myocardial Infarction in Guangxi Han Chinese PopulationJun Li, Rui Qin, Wei Wang, et al.Current Pharmaceutical Biotechnology|May 11, 2011
Using PK/PD to optimize antibiotic dosing for critically ill patientsJason A RobertsCurrent Pharmaceutical Biotechnology|May 11, 2011
How to measure pharmacokinetics in critically ill patients?Xin Liu, Peter S Kruger, Michael S RobertsCurrent Pharmaceutical Biotechnology|May 11, 2011
ARC--augmented renal clearanceAndrew A Udy, Michael T Putt, Robert J Boots, et al.Current Pharmaceutical Biotechnology|May 11, 2011
Dosing of antibiotics in critically ill patients undergoing renal replacement therapyJan T Kielstein, Olaf BurkhardtCurrent Pharmaceutical Biotechnology|May 11, 2011
Physiological changes in the critically ill patient with sepsisShaun Hosein, Andrew A Udy, Jeffrey LipmanCurrent Pharmaceutical Biotechnology|March 31, 2011
Blending of polyethylenimine with a cationic polyurethane greatly enhances both DNA delivery efficacy and reduces the overall cytotoxicityJ Y Cherng, W C Hung, H C KaoCurrent Pharmaceutical Biotechnology|March 31, 2011
Metal release from and sequestration by metallothioneins monitored by electrochemistry and SPRLin Liu, Jianxiu WangCurrent Pharmaceutical Biotechnology|March 31, 2011
Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptideRafal Fudala, Amalendu P Ranjan, Anindita Mukerjee, et al.Current Pharmaceutical Biotechnology|March 16, 2011
Targeting the coagulation factor fibrinogen for arthritis therapyHarini Raghu, Matthew J FlickPageof 302